Key TakeawaysCost per admission is a unit economics problem, not a marketing metric: per-diem rate, ALOS, payer mix, delivery cost, and readmission exposure all sit upstream of acquisition spend.The IPF PPS federal per-diem anchors realized revenue, and clean comorbidity and DRG documentation determines how much of that floor a facility actually collects 7.Volume amplifies whatever per-admission economics already exist, so auditing margin by status, payer, and level of care should precede any push to buy...
